Annual Current Assets
$33.76 M
-$18.57 M-35.48%
31 December 2023
Summary:
Enlivex Therapeutics annual total current assets is currently $33.76 million, with the most recent change of -$18.57 million (-35.48%) on 31 December 2023. During the last 3 years, it has fallen by -$4.36 million (-11.43%). ENLV annual current assets is now -60.94% below its all-time high of $86.44 million, reached on 31 December 2021.ENLV Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$28.57 M
+$194.00 K+0.68%
30 June 2024
Summary:
Enlivex Therapeutics quarterly total current assets is currently $28.57 million, with the most recent change of +$194.00 thousand (+0.68%) on 30 June 2024. Over the past year, it has dropped by -$3.27 million (-10.27%). ENLV quarterly current assets is now -69.53% below its all-time high of $93.78 million, reached on 31 March 2021.ENLV Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.5% | -10.3% |
| 3 y3 years | -11.4% | -68.3% |
| 5 y5 years | +228.5% | +58.1% |
ENLV Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -60.9% | at low | -68.3% | +0.7% |
| 5 y | 5 years | -60.9% | +228.5% | -69.5% | +74.0% |
| alltime | all time | -60.9% | >+9999.0% | -69.5% | +9455.2% |
Enlivex Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $28.57 M(+0.7%) |
| Mar 2024 | - | $28.38 M(-16.0%) |
| Dec 2023 | $3.07 M(-80.0%) | $33.76 M(+6.0%) |
| Sept 2023 | - | $31.84 M(+3.4%) |
| June 2023 | - | $30.79 M(-18.1%) |
| Mar 2023 | - | $37.58 M(-28.2%) |
| Dec 2022 | $15.31 M(+75.9%) | $52.33 M(-11.7%) |
| Sept 2022 | - | $59.23 M(-8.9%) |
| June 2022 | - | $65.05 M(-18.0%) |
| Mar 2022 | - | $79.30 M(-8.3%) |
| Dec 2021 | $8.70 M(+289.1%) | $86.44 M(-4.3%) |
| Sept 2021 | - | $90.28 M(-2.7%) |
| June 2021 | - | $92.83 M(-1.0%) |
| Mar 2021 | - | $93.78 M(+146.0%) |
| Dec 2020 | $2.24 M(+96.4%) | $38.12 M(+20.6%) |
| Sept 2020 | - | $31.61 M(-7.9%) |
| June 2020 | - | $34.33 M(-6.2%) |
| Mar 2020 | - | $36.60 M(+122.9%) |
| Dec 2019 | $1.14 M | $16.42 M(-9.1%) |
| Sept 2019 | - | $18.07 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $19.58 M(+10.1%) |
| Mar 2019 | - | $17.78 M(+73.0%) |
| Dec 2018 | $757.00 K(>+9900.0%) | $10.28 M(+503.1%) |
| June 2018 | - | $1.70 M(-53.0%) |
| Dec 2017 | $0.00(-100.0%) | $3.62 M(-15.4%) |
| Sept 2017 | - | $4.28 M(-22.3%) |
| June 2017 | - | $5.51 M(-29.3%) |
| Mar 2017 | - | $7.80 M(-26.0%) |
| Dec 2016 | $89.00 K(-28.2%) | $10.54 M(-20.6%) |
| Sept 2016 | - | $13.28 M(-21.0%) |
| June 2016 | - | $16.81 M(-24.7%) |
| Mar 2016 | - | $22.33 M(+9.5%) |
| Dec 2015 | $124.00 K(+79.7%) | $20.39 M(-14.3%) |
| Sept 2015 | - | $23.81 M(-11.2%) |
| June 2015 | - | $26.81 M(-9.9%) |
| Mar 2015 | - | $29.76 M(-9.5%) |
| Dec 2014 | $69.00 K(+885.7%) | $32.88 M(-4.6%) |
| Sept 2014 | - | $34.48 M(+685.8%) |
| June 2014 | - | $4.39 M(+1367.2%) |
| Dec 2013 | $7000.00(>+9900.0%) | $299.00 K |
| Dec 2012 | $0.00 | - |
FAQ
- What is Enlivex Therapeutics annual total current assets?
- What is the all time high annual current assets for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual current assets year-on-year change?
- What is Enlivex Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly current assets year-on-year change?
What is Enlivex Therapeutics annual total current assets?
The current annual current assets of ENLV is $33.76 M
What is the all time high annual current assets for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual total current assets is $86.44 M
What is Enlivex Therapeutics annual current assets year-on-year change?
Over the past year, ENLV annual total current assets has changed by -$18.57 M (-35.48%)
What is Enlivex Therapeutics quarterly total current assets?
The current quarterly current assets of ENLV is $28.57 M
What is the all time high quarterly current assets for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly total current assets is $93.78 M
What is Enlivex Therapeutics quarterly current assets year-on-year change?
Over the past year, ENLV quarterly total current assets has changed by -$3.27 M (-10.27%)